TIDMAGI

RNS Number : 3797V

Peel Hunt LLP

11 January 2012

 
                                FORM 8.3 
 
                           IRISH TAKEOVER PANEL 
 
                  DISCLOSURE UNDER RULE 8.3 OF THE IRISH 
                    TAKEOVER PANEL ACT, 1997, TAKEOVER 
                         RULES, 2007 (AS AMENDED) 
 
                    DEALINGS BY PERSONS WITH INTERESTS 
                   IN RELEVANT SECURITIES REPRESENTING 
                                1% OR MORE 
 
                            1. KEY INFORMATION 
================================================================= 
Name of person dealing          Peel Hunt LLP 
 (Note 1) 
=============================  ================================== 
Company dealt in                AGI Therapeutics 
                                 Plc 
=============================  ================================== 
Class of relevant              Ordinary Shares of 
 security to which              EUR0.01 each 
 the dealings being 
 disclosed relate 
 (Note 2) 
=============================  ================================== 
Date of dealing                 9 January 2012 
=============================  ================================== 
 
 
  2. INTERESTS AND SHORT POSITIONS 
 
  (a) Interests and short positions 
  (following dealing) in the class of 
  relevant security dealt in (Note 3) 
================================================================= 
                                          Long              Short 
=============================  ===============  ================= 
                               Number (%)        Number (%) 
=============================  ===============  ================= 
                               1,876,749 
(1) Relevant securities         (2.78%) 
=============================  ===============  ================= 
(2) Derivatives 
 (other than options) 
=============================  ===============  ================= 
(3) Options and 
 agreements to purchase/sell 
=============================  ===============  ================= 
                               1,876,749 
Total                           (2.78%) 
=============================  ===============  ================= 
 (b) Interests and short positions 
  in relevant securities of the company, 
  other than the class dealt in (Note 
  3) 
================================================================= 
Class of relevant                         Long              Short 
 security: 
=============================  ===============  ================= 
                               Number (%)        Number (%) 
=============================  ===============  ================= 
 
 (1) Relevant securities 
=============================  ===============  ================= 
 
 (2) Derivatives 
 (other than options) 
=============================  ===============  ================= 
 
 (3) Options and 
 agreements to purchase/sell 
=============================  ===============  ================= 
 
 Total 
=============================  ===============  ================= 
 
 
 
 
                                                  1 February 2009 
 
 
 
   3. 
    DEALINGS 
    (Note 
    4) 
 
    (a) 
    Purchases 
    and 
    sales 
   =========================================================================================================== 
 
    Purchase/sale              Number of relevant                              Price per 
                               securities                                      unit (Note 
                                                                               5) 
   ==================  =================================================  ==================================== 
   Purchase            2,146,833                                          7 
    Purchase            4,254                                              7.0125 
    Purchase            89,843                                             6.855 
    Purchase            80,000                                             6.5825 
    Purchase            5,000                                              6.6575 
    Purchase            50,000                                             6.7475 
    Purchase            11,152                                             6.8075 
    Purchase            32,750                                             6.9575 
    Purchase            40,150                                             7.125 
   ==================  =================================================  ==================================== 
   Sale                99,500                                             7.2 
    Sale                100,000                                            7.2375 
    Sale                275,479                                            7.25 
    Sale                150,000                                            8.9999 
   ==================  =================================================  ==================================== 
 
 
    (b) 
    Derivatives 
    transactions 
    (other 
    than 
    options 
    transactions) 
   =========================================================================================================== 
   Product 
    name,             Nature of             Number of relevant                            Price 
    e.g. CFD          transaction           securities                                    per unit 
 
                      (Note 6)              (Note 7)                                      (Note 
                                                                                          5) 
   ================  ====================  ===========================================  ====================== 
 
 
 
    (c) 
    Options 
    transactions 
    in 
    respect 
    of 
    existing 
    relevant 
    securities 
 
    (i) 
    Writing, 
    selling, 
    purchasing 
    or 
    varying 
   =========================================================================================================== 
   Product         Writing,              Number             Exercise    Type,         Expiry    Option 
    name,          selling,              of securities       price      e.g.          date       money 
    e.g.           purchasing,           to which                       American,                paid/received 
    call           varying               the option                     European                 per 
    option         etc.                  relates                        etc.                     unit 
                                         (Note                                                   (Note 
                                         7)                                                      5) 
   ==============  ====================  ================  ===========  ============  ========  ============== 
 
 
 
 
    (ii) 
    Exercising 
   =========================================================================================================== 
   Product name,              Number of securities                            Exercise 
    e.g. call                                                                  price per 
    option                                                                     unit (Note 
                                                                               5) 
   ==================  =================================================  ==================================== 
 
 
 
 
    (d) 
    Other 
    dealings 
    (including 
    transactions 
    in 
    respect 
    of 
    new 
    securities) 
    (Note 
    4) 
   =========================================================================================================== 
   Nature of                  Details                                         Price per 
    transaction                                                                unit 
    (Note 8)                                                                   (if applicable) 
                                                                               (Note 5) 
   ==================  =================================================  ==================================== 
 
 
 
 
 
 
 
                                                                                                             1 
                                                                                                      February 
                                                                                                          2009 
 
 
 
4. OTHER INFORMATION 
 
 Agreements, arrangements or understandings 
 relating to options or derivatives 
================================================= 
Full details of any agreement, arrangement 
 or understanding between the person 
 disclosing and any other person relating 
 to the voting rights of any relevant 
 securities under any option referred 
 to on this form or relating to the 
 voting rights or future acquisition 
 or disposal of any relevant securities 
 to which any derivative referred to 
 on this form is referenced. If none, 
 this should be stated. 
================================================= 
 
 
 
 
 Is a Supplemental Form 8 attached? 
 (Note 9) YES/NO 
================================================= 
Date of disclosure            11(th) January 2012 
============================  =================== 
Contact name                   Kelly Morgan 
============================  =================== 
Telephone number               0207 418 8860 
============================  =================== 
If a connected EFM,           N/A 
 name of offeree/offeror 
 with which connected 
============================  =================== 
If a connected EFM,           N/A 
 state nature of connection 
 (Note 10) 
============================  =================== 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                  1 February 2009 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RETLLFLFLEILLIF

AGI (LSE:AGI)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more AGI Charts.
AGI (LSE:AGI)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more AGI Charts.